RxDoctor Payments DataLook up a doctor →

Munni Selagamsetty, MD

Internal Medicine · Colorado Springs, CONPI 1588621072

Payments from drug & device makers

$56,166in general payments, 2019–2025

Across 879 payments — averaging $63.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$29K
  • AstraZeneca$7K
  • Sanofi-aventis U.S. LLC$6K
  • AbbVie$2K
  • Novo Nordisk$2K
  • Novartis$1K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)143$29,165
AstraZeneca(2 entities)109$6,843
Sanofi-aventis U.S. LLC22$5,863
AbbVie(2 entities)94$1,598
Novo Nordisk63$1,500
Novartis21$1,042
Novo Nordisk AS1$1,000
Boehringer Ingelheim34$918
Lilly USA, LLC50$862
Esperion Therapeutics, Inc.15$572
Pfizer37$515
Corcept Therapeutics22$454
Astellas Pharma US Inc16$404
Bayer22$357
Abbott20$342
Madrigal Pharmaceuticals9$340
Johnson & Johnson21$331
Amarin Pharma, Inc.9$267
Exact Sciences10$218
Merck12$211
Paratek Pharmaceuticals, Inc.11$196
Bausch Health US, LLC9$182
Heartflow, Inc.1$167
Regeneron Healthcare Solutions, Inc.4$162
Aimmune Therapeutics, Inc.3$158
GSK11$141
Kowa Pharmaceuticals America, Inc.3$134
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$125
Echosens North America, Inc.3$111
Vanda Pharmaceuticals Inc.5$101
Endo Pharmaceuticals Inc.6$97
Idorsia Pharmaceuticals US Inc5$96
E.r. Squibb & Sons, L.L.C.4$92
Sumitomo Pharma America, Inc.5$87
Sunovion Pharmaceuticals Inc.5$87
ANI Pharmaceuticals, Inc.1$85
Medtronic(2 entities)4$82
Astellas Pharma Global Development1$82
Nestle Healthcare Nutrition Inc.4$78
Grifols USA, LLC3$77
Takeda Pharmaceuticals U.S.A., Inc.4$76
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$68
Renalytix AI, Inc.1$60
Edwards Lifesciences2$59
Dexcom, Inc.3$54
BETA Bionics, Inc.2$53
Optos, Inc.3$46
Eisai Inc.2$40
Ultragenyx Pharmaceutical Inc.2$39
Insulet Corporation2$38
Antares Pharma, Inc.2$36
Otsuka America Pharmaceutical, Inc.2$35
Galderma Laboratories, L.p.2$35
Nevro Corp.1$32
Pulmonx Corporation1$31
Biohaven Pharmaceuticals, Inc.2$29
Inogen, Inc.2$28
Avanir Pharmaceuticals, Inc.2$27
Inspire Medical Systems, Inc.1$25
Travere Therapeutics, Inc.3$25

How this compares

$56,166 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$249,175
Medicare patients
233
Services billed
2,828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Colorado Springs

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →